科普赋能：让医疗科技触手可及 随着我国老年人口突破3 亿大关，老龄化带来的健康挑战与社会负担日益凸显。围绕人口老龄化加速背 景下的银龄健康需求，波士顿科学带来了多款与中国老龄患者需求紧密契合的微创介入解决方案，包括 用于房颤治疗的明星产品FARAWAVE NAV一次性使用磁定位心脏脉冲电场消融导管；房颤患者卒中预 防"利器"新一代WATCHMAN FLX Pro左心耳封堵器；用于心脏节律管理的S-ICD皮下植入式除颤器和 起搏器、除颤器；治疗良性前列腺增生的Rezūm前列腺热蒸汽治疗系列产品，以及神经调控领域改善帕 金森病症状的Vercise Genus植入式脑深部神经刺激（DBS）系列产品。 波士顿科学还带来多项突破性疗法，为患者带来更多元的治疗选择：可预防经导管主动脉瓣置换术 （TAVR）中发生脑卒中的SENTINEL抗栓塞脑保护装置 ；用于颈动脉狭窄创新术式经颈动脉血管重建 术（TCAR）的ENROUTE经颈动脉逆流血栓保护装置 ；用于原发性肝癌治疗的TheraSphere Y90钇 [90Y]玻璃微球系统；美国FDA唯一批准的肝动脉灌注（HAI）疗法产品Intera3000肝动脉灌注泵* ，为 结直肠 ...

0:00 进博"断货王"极速返场掀抢购潮 （潘洁拍摄、剪辑） 12月19日至21日，首届进博优品交易会在国家会展中心（上海）正式启幕。作为进博会会期之外的特定领域优质产品延展活动，此次交易会也是"共享 大市场·出口中国"系列活动的关键一环。 记者在现场看到，3H馆与4.1H馆内人头攒动，来自60多个国家的700多家企业携优质产品参展，直面消费者，让更多"进博同款"走入大众视野。 展台上，既有大洋洲直供的天然健康食品、欧洲匠心打造的精致家用设备，也有风靡美洲的潮流个护好物、尽显亚洲风情的特色美妆产品，款款皆是备 受追捧的"进博同款"新品。 这场主打消费体验的"小进博"，开展首日便吸引了众多进博会"老朋友"。其中，雅诗兰黛集团以集合店形式亮相，集结旗下12大品牌，倩碧、朗仕、汤 姆福特等品牌带来覆盖护肤、彩妆、香氛等品类的百余款新品，为消费者带来丰富的选购选择。 在"进博优品会"上，新西兰纽仕兰乳业展台没有采用传统的静态陈列，而是将展台全方位打造为一个沉浸式360度全景直播场域。 "进博会上的'断货王'，紧急空运惊喜放送，展台与直播间皆可轻松入手。"在"进博优品会"的现场，纽仕兰展台的主播正举着一罐牛初乳奶粉热情 ...

Group 1: Innovations in Low-altitude Travel - The first manned ducted flying vehicle showcased at the expo can reach a maximum altitude of 1000 meters, with a flight duration of approximately 20 minutes and a top speed of 80 km/h, capable of carrying 100 kg [1] - The flying vehicle features ground station-assisted control, allowing operators to perform simple operations for hovering, which enhances aerodynamic efficiency compared to traditional propeller designs [1] Group 2: Market Dynamics and Innovation - The expo has transformed from a platform for international procurement to a showcase for innovation, with companies eager to display their latest technological advancements [2] - The competitive and vibrant Chinese market is a significant driver for innovation, as companies believe that success in China can lead to global success [3] - The "Local for Local" strategy adopted by companies aims to leverage local resources to accelerate innovation and enhance consumer experiences [3] Group 3: Support for Small Enterprises - The "Innovation Incubation Zone" at the expo focuses on showcasing the latest achievements of small tech companies, providing them with a platform for commercialization [4] - The expo serves as a testing ground for foreign companies to assess their adaptability and innovation capabilities in the Chinese market [4] Group 4: Collaborative Innovation - The shift from merely importing advanced technologies to co-developing solutions that meet local clinical needs reflects a new approach in the industry [5] - The expo is now seen as a catalyst for accelerating the implementation of innovative solutions, with numerous new products and technologies launched [5]

Group 1 - The eighth China International Import Expo showcased various innovative technologies, including air taxis, wearable flying devices, smart exoskeletons, and autonomous vehicles, indicating a rapid transition from science fiction to reality [1][2] - The M1 manned flying vehicle from Yufeng Future features a composite wing design and pure electric energy, capable of carrying five people with a range of 250 kilometers and a cruising speed of 200 kilometers per hour, offering a 15-minute flight from the National Exhibition Center to Yangcheng Lake at a ticket price of 109 yuan [1] - The world's first wearable ducted manned flying device developed by Hangzhou Zhiyuan Research Institute can reach a maximum altitude of 1,000 meters and has a flight duration of approximately 20 minutes, designed to free the hands of the user for emergency rescue operations [1] Group 2 - The Orbera365 endoscopic gastric balloon system by Boston Scientific fills a technological gap in the domestic endoscopic weight loss field, using a saline-filled "water ball" to occupy part of the stomach volume, reducing food intake and enhancing satiety for patients [2] - The VIATRIX exoskeleton robot developed by Shanghai Aoshark Intelligent can learn the user's gait through AI adaptive mode, providing intelligent assistance for various activities such as walking, climbing, and cycling, with a single battery supporting a range of up to 25 kilometers [2] - Tesla's Cyber Autonomous Electric Vehicle made its Asia-Pacific debut at the expo, featuring no steering wheel or pedals, representing a significant advancement in AI-driven technology and the potential for a new era of transportation [2]

Core Insights - The eighth China International Import Expo (CIIE) showcased 461 new products, technologies, and services, highlighting innovations such as humanoid robots and autonomous vehicles, which depict a vision of future living [1][2][4] Group 1: New Product Launches - The expo featured a significant number of global debuts, with over 200 new products, nearly half being world premieres, indicating a clear trend towards high-tech and innovative solutions [2] - Notable launches included L600, the world's first full-size tilt-duct wing eVTOL with a range of 600 kilometers, and Philips' AI lighting solutions for personalized home experiences [2][4] - Health-focused innovations were also prominent, such as Medtronic's closed-loop rechargeable spinal nerve stimulation system and BD's closed-system intravenous catheter [2] Group 2: AI and Robotics Integration - The integration of AI in consumer products was a key theme, with various companies showcasing AI-driven solutions for home management and healthcare, such as Samsung's AI Home system and GE Healthcare's surgical robots [5][6] - Humanoid robots demonstrated capabilities in various tasks, attracting significant attention and showcasing the potential for AI in everyday life [5][8] Group 3: Health and Wellness Trends - The expo emphasized health management, with companies like Boston Scientific and Novo Nordisk introducing innovative products aimed at weight management and obesity awareness [7] - The concept of "proactive health" was introduced, encouraging consumers to shift from reactive to proactive health management, with a focus on low-fat and high-protein food options [7] Group 4: Emotional and Pet Economy - The emotional value of products was highlighted, with brands targeting younger consumers who prioritize emotional connections in their purchases [10] - The pet economy was also a focus, with a dedicated area for pet products, reflecting the growing trend of pets as family members, projected to exceed 811.4 billion yuan by 2025 [12]

Core Insights - The eighth China International Import Expo (CIIE) showcased 461 new products, technologies, and services, establishing itself as a platform for global innovation and market entry [2] - Major global companies in the medical device and healthcare sectors, including Johnson & Johnson, Roche, and Pfizer, participated, highlighting the expo's role in promoting high-end medical equipment and innovative pharmaceuticals [2][3] - The expo has accelerated the registration and market entry processes for new medical products, exemplified by Medtronic's Micra product, which achieved rapid commercialization following its global debut at the first CIIE [3] Medical Devices and Healthcare - The expo featured significant innovations such as Johnson & Johnson's ETHICON 4000 3D stapler and Siemens Healthineers' ARTIS icono ceiling Xpand, indicating a shift in China's high-end medical device sector from "catching up" to "leading" [2] - Medtronic's focus on AI integration in healthcare was evident with the introduction of seven new products, showcasing the company's commitment to innovation in the medical field [2][3] - The integration of clinical practitioners and entrepreneurs is expected to foster more original innovations in the healthcare sector [2] Consumer Trends - The expo introduced new themes such as the silver economy, ice and snow economy, and sports economy, along with platforms for digital and health consumption, enhancing consumer experiences [3] - Companies like JoShan Health Technology showcased an AI-driven health management ecosystem, reflecting a trend towards personalized and intelligent home fitness solutions [4] Economic Impact - Panasonic highlighted its innovative products aimed at enhancing quality of life, emphasizing the dual focus on user scenarios and AI industry infrastructure development in China [5] - Shanghai has rapidly developed its first-launch economy, hosting over 2,000 first-launch events this year and seeing significant growth in e-commerce transactions, with a 12.7% year-on-year increase [5]

0:00 当"管不住嘴"遇上"减重新科技" 体重超标者有了新选择！ Orbera365内镜引导胃减容球囊系统 产品通过内窥镜将球囊送入胃内 通过占据部分胃容积 减少进食量 延迟胃排空 增强饱腹感 手术操作简单 植入过程大概20多分钟 5分钟左右便可快速取出 球囊最长留置12个月 第八届进博会上 展出了一款不打针、不吃药的减重利器 总监制丨唐怡 策划丨刘峻廷 编导丨陈汉坤 王默晗 汪泽源 摄像丨李东宇 余樵 责编：张青津、卢思宇 术后可正常生活工作 实现"隐形减重" 进博会作为"医学未来实验室" 将新科技逐步带入大众生活 ...

Core Insights - The global and Chinese obesity population is expanding, posing significant public health challenges, with predictions indicating that by 2030, 515.04 million adults in China will be overweight or obese [1] - The Chinese government is intensifying efforts to combat obesity, officially incorporating weight management into the "Healthy China Action" for 2024, highlighting the importance of obesity prevention [2] - The eighth China International Import Expo (CIIE) showcased various products and solutions aimed at obesity prevention and management, reflecting the growing focus on this health issue [1][2] Group 1: Obesity Statistics and Health Risks - The World Obesity Federation's report predicts that by 2025, 41% of Chinese adults will be overweight, and 9% will be obese, with obesity becoming the sixth leading cause of death and disability in China [1] - If no urgent interventions are taken, by 2050, 50% of adults and one-third of children globally will face overweight or obesity issues [1] Group 2: Government Initiatives and Industry Response - The National Health Commission is launching a three-year action plan for weight management, emphasizing the need for public awareness and education regarding obesity [2] - Companies are innovating in treatment options, including lifestyle interventions, anti-obesity medications, and metabolic surgery, to provide diverse solutions for obesity management [2][5] Group 3: Innovative Solutions at CIIE - Novo Nordisk introduced an immersive experience space focused on obesity management, promoting public engagement and education on the condition [2][3] - The GLP-1 medication, Semaglutide, has shown significant clinical benefits, including a 20% reduction in major adverse cardiovascular events and weight loss in approximately one-third of patients [4] - Johnson & Johnson presented advanced surgical solutions, including the ETHICON 4000 3D stapler, which enhances surgical precision and reduces complications [5] Group 4: Nutritional Interventions and Market Strategies - Boston Scientific showcased innovative weight management products, such as the Orbera365 intragastric balloon system, which aids in temporary weight loss for patients with specific BMI criteria [6] - Herbalife emphasized its commitment to the Chinese market, planning to leverage local insights for global innovation while contributing to the "Healthy China 2030" vision [7]

Core Insights - The 8th China International Import Expo (CIIE) opened in Shanghai on November 5, showcasing innovations in the medical device and pharmaceutical sectors under the theme "Healthy China, Beautiful Life" [1] - The medical device and pharmaceutical health exhibition area, known for its high competition, featured global leaders in medical technology and pharmaceuticals, including the top ten medical device companies and 11 Fortune 500 pharmaceutical firms [1] Company Highlights - **Roche**: Displayed over 40 products, including new treatments for Alzheimer's, Parkinson's, and lupus nephritis, with the anti-CD20 monoclonal antibody, Gazyva, and the Port Delivery System (PDS) for eye diseases being key highlights [2][4][5] - **Siemens**: Focused on high-incidence cancers, showcasing advanced technologies like the ARTIS icono ceiling Xpand and the Biograph Vision Quadra PET/CT, aimed at improving diagnostic precision and treatment outcomes [6][7] - **Novartis**: Presented nearly 20 innovative products, including the oral complement factor B inhibitor, Iptacopan, and the radioligand therapy drug, Pluvicto, which received approval for prostate cancer indications [10][12] - **Fosun Pharma**: Introduced the Marie upright particle therapy system, a revolutionary cancer treatment technology, along with advanced non-invasive treatment systems for neurological conditions [12][14] - **Boston Scientific**: Showcased over 80 products in the minimally invasive intervention field, including the Orbera365 gastric balloon system and the Intera3000 hepatic artery infusion pump, with several products making their debut [15][17] - **Novo Nordisk**: Highlighted advancements in diabetes and obesity treatments, including the oral GLP-1 receptor agonist, Rybelsus, and the weekly insulin formulation, IcoSema, which have significantly improved patient convenience [18][20]

Core Insights - The eighth China International Import Expo (CIIE) showcased several innovative medical devices and healthcare products, attracting significant attention from global trade delegations [1][2] Group 1: Medical Devices - Boston Scientific presented the ENROUTE Transcarotid Artery Revascularization (TCAR) device, the first and only approved device for TCAR procedures, aimed at reducing intraoperative risks associated with carotid artery stenosis [1] - Another product from Boston Scientific, the FARAWAVE NAV catheter, utilizes non-thermal electric fields for cardiac tissue ablation and has treated approximately 500,000 patients globally [1] - Medtronic introduced the Inceptiv closed-loop rechargeable spinal nerve stimulation system, designed to improve the quality of life for patients with chronic pain through weak electrical stimulation [4] - BD Medical showcased the M.R.I™ 4F Slim Implantable Port, the thinnest catheter in its category, designed for the Chinese population, which significantly reduces thrombosis rates by 40% [4] - The Venclose™ catheter, designed for treating lower limb varicose veins, features a flexible setup that minimizes patient trauma [5] Group 2: Innovative Treatments - Fosun Pharma presented the Exablate Neuro system, a high-intensity focused ultrasound (HIFU) device combined with MRI for treating drug-resistant essential tremors and Parkinson's disease [6] - Eli Lilly introduced innovative drugs targeting aging and obesity, including donanemab for Alzheimer's disease, which has shown to delay disease progression by approximately 30% in clinical trials [6]